AI Developer

Watts Water Technologies shares rose 3.1% after Keybanc upgraded the stock to "Overweight" from "Sector Weight" with a $340 price target, representing a 17.5% potential upside. Analyst Jeffrey Hammond cited the company's prospects as "too compelling to ignore", even without improvement in main markets. The upgrade was based on expected pricing tailwinds, growth from the data centre business and recent merger and acquisition activity. Keybanc believes the market underappreciates the company's emerging acquisition strategy. Watts Water previously reported strong fourth-quarter results with margin expansion offsetting volume declines. The stock has risen 7.1% year-to-date and recently hit a new 52-week high of $298.26 per share.

Companies with more cash than debt can be financially resilient, but that doesn't mean they're all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers. Financial flexibility is valuable, but it's not everything - at StockStory, we help you find the stocks that can not only survive but also outperform. Keeping that in mind, here are two companies with net cash positions that can continue growing sustainably and one with hidden risks. Net Cash Position: $174.2 million (16.4% of Market Cap) Founded in 1971, Marcus & Millichap (NYSE:MMI) specializes in commercial real estate investment sales, financing, research, and advisory services. Why Should You Sell MMI? Lackluster 1.3% annual revenue growth over the last five years indicates the company is losing ground to competitors Poor free cash flow margin of 3% for the last two years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results At $27.12 per share, Marcus & Millichap trades at 59.1x forward P/E. To fully understand why you should be careful with MMI, check out our full research report (it's free) Net Cash Position: $260.2 million (2.6% of Market Cap) Founded in 1874, Watts Water (NYSE:WTS) specializes in manufacturing water products and systems for residential, commercial, and industrial applications globally. Why Are We Bullish on WTS? 9.3% annual revenue growth over the last five years surpassed the sector average as its offerings resonated with customers Offerings are mission-critical for businesses and result in a best-in-class gross margin of 45.9% Performance over the past five years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue Watts Water Technologies is trading at $297.29 per share, or 26.8x forward P/E. Is now a good time to buy? See for yourself in our full research report, it's free Net Cash Position: $141.4 million (0.8% of Market Cap) Founded in 1992 as a scientifically-driven alternative to traditional contract research organizations, Medpace (NASDAQ:MEDP) provides outsourced clinical trial management and research services to help pharmaceutical, biotechnology, and medical device companies develop new treatments. Why Do We Watch MEDP? Existing business lines can expand without risky acquisitions as its organic revenue growth averaged 15.1% over the past two years Market share is on track to rise over the next 12 months as its 17.9% projected revenue growth implies demand will accelerate from its two-year trend Performance over the past five years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue

Watts Water completes its cash-funded buy of Saudi Cast, a Riyadh-based drainage maker with about $20 million in annualized sales, expanding its APMEA reach.